Human Pathology
Volume 41, Issue 11 , Pages 1601-1608, November 2010

High-definition characterization of cerebral β-amyloid angiopathy in Alzheimer's disease☆☆

  • Virawudh Soontornniyomkij, MD

      Affiliations

    • Department of Pathology and Laboratory Medicine (Neuropathology), David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA
    • Department of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA 92093-0603, USA
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0603, USA.
  • ,
  • Cecilia Choi, MS

      Affiliations

    • Department of Pathology and Laboratory Medicine (Neuropathology), David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA
  • ,
  • Justine Pomakian, MPH

      Affiliations

    • Department of Pathology and Laboratory Medicine (Neuropathology), David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA
  • ,
  • Harry V. Vinters, MD

      Affiliations

    • Department of Pathology and Laboratory Medicine (Neuropathology), David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA
    • Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA

Received 4 February 2010; received in revised form 20 April 2010; accepted 30 April 2010. published online 05 August 2010.

Summary 

The occurrence and progression of cerebral β-amyloid angiopathy and β-amyloid plaques in sporadic Alzheimer's disease may be attributed to aging-related deficiencies in β-amyloid drainage along cerebral perivascular pathways. To elucidate high-definition characteristics of cerebral β-amyloid deposition, we performed immunogold silver staining for β-amyloid-40 and β-amyloid-42 on semithin LR White-embedded tissue sections from 7 Alzheimer's disease/severe cerebral β-amyloid angiopathy, 9 Alzheimer's disease/mild cerebral β-amyloid angiopathy, 5 old control, and 4 young control autopsy brains. In vessel walls, β-amyloid-40 and β-amyloid-42 deposits were unevenly distributed along the adventitia and among the medial smooth muscle cells. β-Amyloid-40 immunoreactivity appeared greater than that of β-amyloid-42 in vessel walls, with β-amyloid-42 being preferentially located on their abluminal regions. In capillary walls, either β-amyloid-40 or β-amyloid-42 deposits or both were present in 6 of 7 severe cerebral β-amyloid angiopathy and in 1 of 9 mild cerebral β-amyloid angiopathy cases, with a marked variation in thickness and focally abluminal excrescences. In 5 of 7 severe cerebral β-amyloid angiopathy cases, a subset of β-amyloid-laden capillaries revealed either β-amyloid-40 or β-amyloid-42 deposits or both radiating from their walls into the surrounding neuropil (“pericapillary deposits”). No vascular β-amyloid-40 or β-amyloid-42 deposits were observed in any of the controls. In conclusion, the patterns of β-amyloid-42 and β-amyloid-40 immunoreactivity in vessel walls suggest that β-amyloid deposits occur in the vascular basement membranes along cerebral perivascular drainage pathways, extending from cortical capillaries to leptomeningeal arteries. The presence of pericapillary β-amyloid deposits suggests that a subset of β-amyloid plaques originate from β-amyloid-laden capillaries, particularly in Alzheimer's disease brains that exhibit preferential capillary involvement by cerebral β-amyloid angiopathy.

Abbreviations: Aβ, β-amyloid, AD, Alzheimer's disease, CAA, cerebral Aβ angiopathy, MA, brains of AD patients with mild CAA, SA, brains of AD patients with severe CAA, OC, brains of non demented old controls, YC, brains of non demented young controls

Keywords: Cerebral amyloid angiopathy, LR White resin, Immunogold silver staining

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work was supported by the US National Institute on Aging grants P50 AG16570 and P01 AG12435, and the Dalijit S. & Elaine Sarkaria Chair in Diagnostic Medicine held by H.V.V., as well as an interdisciplinary research fellowship in neuroAIDS in the US National Institute of Health grant MH81482 to V.S.

☆☆ Disclosure: There are no real or potential conflicts of interest for any of the authors to disclose.

PII: S0046-8177(10)00161-9

doi:10.1016/j.humpath.2010.04.011

Human Pathology
Volume 41, Issue 11 , Pages 1601-1608, November 2010